by John Conrad | Jan 8, 2024 | iBIO News
CHICAGO, Ill., Jan. 8, 2024 – Today, the Illinois Biotechnology Innovation Organization, iBIO, the trade association representing the 91,000 jobs in Illinois’ life sciences sector, announced a new Chair and added three new members to its Board of Directors. Ken...
by John Conrad | Jan 8, 2024 | iBIO News
Dr. Ken Johnson, an industry expert with over 30 years of experience in pharmaceuticals and academia, has been elected as the Chair of the Board for the Illinois Biotechnology Innovation Organization (iBIO). With his extensive knowledge and expertise, Dr. Johnson is...
by John Conrad | Jan 5, 2024 | iBIO in the News
On January 3rd iBIO president & CEO, John Conrad, joined his biosciences colleagues from across the country to ring the closing bell at the New York Stock Exchange (NYSE). And to talk about the industry in 2024 and the amazing growth of our life sciences industry...
by John Conrad | Jan 2, 2024 | Policy News
We want to take a moment to recognize Congressman Brad Schneider for his leadership and advocacy on behalf of the biopharmaceutical industry. His recent letter to the U.S. Trade Representative opposing the proposed expansion of the waiver of IP rights for COVID...
by John Conrad | Dec 10, 2023 | iBIO News
Access to capital is the #1 issue we hear from our members, so we are offering a NEW member-only service to help iBIO Members access non-dilutive funding from the government. By teaming up with G2G Consulting, which has secured over $528 million in government funding...
by John Conrad | Dec 4, 2023 | iBIO News
The Timothy P. Walbert Entrepreneurship Impact Award will provide much-needed early-stage capital to the most promising startups in the biosciences industry. Chicago, IL – The iBIO Institute has received a donation from Tim Walbert, former chairman, president...
by John Conrad | Nov 20, 2023 | Policy News
iBIO, a life sciences industry association representing over 91,000 jobs in Illinois, joined over 100 stakeholders last week in urging Congress to reauthorize the Pandemic and All-Hazards Preparedness Act (PAHPA). PAHPA expired on September 30, 2023, requiring...
by John Conrad | Nov 16, 2023 | iBIO News
For a limited time, iBIO Members can save on BIO 2024 International Convention registration. The BIO International Convention is the largest and most consequential gathering of the biotech community in the world. Join us June 3-6, 2024, at the San Diego Convention...
by John Conrad | Nov 10, 2023 | iBIO News
Access to capital is the #1 issue we hear from our members, so we are offering a NEW member-only service to help iBIO Members access non-dilutive funding from the government. By teaming up with G2G Consulting, which has secured over $528 million in government funding...
by John Conrad | Nov 9, 2023 | Policy News
As startup funding is increasingly harder for Illinois startup companies to raise, it is more critical than ever that we support American innovation and job creation. However, a harmful change in the tax code threatens to stifle these efforts, especially for small...
